Epicardial Adipose Tissue And Coronary Risk In HIV-Infected Patients (ANRS EP 52)
EPICARDIAL ADIPOSE TISSUE AND CORONARY RISK IN HIV-INFECTED PATIENTS
Protocol date and version RCB Id : 2013-A00547-38
Etude ANRS EP 52 PIECVIH Title of Study: EPICARDIAL ADIPOSE TISSUE AND CORONARY RISK IN HIV-INFECTED PATIENTS
Short title - PIECVIH study
Sponsor French National Institute for Health and Medical Research - French national agency for research on AIDS and viral hepatitis (Inserm-ANRS)
Coordinating Investigator Pr Franck BOCCARA Service de Cardiologie, Hôpital St Antoine INSERM UMRS 938 Paris, UPMC, Institut hospitalo-Universitaire- Institute of Cardiometabolism and Nutrition (IHU-ICAN) 184, rue du Faubourg Saint-Antoine 75571 PARIS Cedex 12 Tél. : 01 49 28 24 49 - Fax : 01 49 28 26 83 Courriel : franck.boccara@sat.aphp.fr
Participating country: France
Objectives Principal objective To compare the inflammatory profile of the epicardial adipose tissue (EAT) between people living with and without HIVwho present with coronary heart disease and will undergo a coronary artery bypass graft (CABG)
Secondary objectives
- To compare the volume of EAT between people living with and without HIV who present with coronary heart disease
- To evaluate the relationship between the abnormalities of the expression profiles of the adipocytokines and cytokines with the atherosclerotic lesions.
- To evaluate the relationship between the abnormalities of the expression profiles of the adipocytokines and cytokines of the EAT with the circulating levels and metabolic parameters.
- To compare the histological and inflammatory profiles of the EAT with the subcutaneous adipose tissue for each patient individually.
Methodology multicentric, comparative study
Estimated enrollment 31 participants in total
- st group of- 15 people living with HIV undergoing CABG (coronary heart disease HIV+ group)
- nd group of- 16 people without HIV- undergoing CABG (coronary heart disease HIV- group) People without HIV-will be matched to people living with HIV+ by : age (± 5 years) and sex Outcomes
Primary outcome:
Comparative analysis of the inflammatory profile of the EAT : expression profile of the pro and anti inflammatory cytokines and adipokines within the EAT in both groups of participants : coronary heart disease HIV+ and HIV- groups
Secondary outcomes :
- Determination of the EAT volume by echocardiography and cardiac scanner for both groups
- Macroscopic profile of the EAT : adipocytes, fibrosis, endothelial cell density)
- RT-PCR analyses : renin, adiponectine, PPARɣ
- Comparatison of the inflammatory and macroscopic profiles between the EAT and the subcutaneous adipose tissue in the two groups by ARN messagers analysis.
Eligibility Inclusion criteria HIV+ group
- Men or women above the age of 18 years old, HIV1 seropositive for more than 6 months
- Individual undergoing, for the first time, cardiac surgery for CABG
- Affiliated with a social security regimen (the AME is not a social security regimen)
- Signed the consent form
HIV- group
- Men or women above the age of 18 years old, HIV seronegative
- Individuals undergoing, for the first time, cardiac surgery for CABG
- Affiliated with a social security regimen (the AME is not a social security regimen)
- Signed the consent form
Non-inclusion criteria History of surgery for CBAG and/or congenital heart defect- being under the tutorship or guardianship of the state or in custody of the justice system.
Statistical methods Categorical variables will be compared using Fisher's exact test. Continuous variables will be compared using the Student's t-test (parametric) and the Wilcoxon-Mann-Whitney test (non-parametric) as appropriate considering the data distribution. (statistical analysis software STATA 11 (StataCorp, Texas, USA))
Provisional study planning and timetable Study start date: July 2013 Enrollment period: 32 months Subject participation duration: 24 hours Total study duration: 32 months Estimated study completion date: end of March 2016
研究概览
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
-
Paris、法国、75012
- Hospital St Antoine
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
VIH + GROUP:
- Men or women > 18 years old, HIV1 + for more than 6 months
- Planned first cardiac surgery for CABG
VIH - GROUP:
- Men or women > 18 years old,
- Planned first cardiac surgery for CABG
Exclusion Criteria:
- History of cardiac surgery
学习计划
研究是如何设计的?
设计细节
- 分配:不适用
- 介入模型:单组作业
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
---|---|
其他:no Arm
|
研究衡量的是什么?
主要结果指标
结果测量 |
大体时间 |
---|---|
comparison of the inflammatory profile of the epicardial adipose (EAT) tissue between HIV-infected and uninfected patients undergoing cardiac surgery for coronary artery bypass graft (CABG)
大体时间:day 1
|
day 1
|
次要结果测量
结果测量 |
大体时间 |
---|---|
comparison the volume of EAT between HIV-infected and uninfected patients undergoing cardiac surgery
大体时间:day 1
|
day 1
|
Evaluation of the relations between the adipocytokines and cytokines profile in the EAT and in the systemic circulation.
大体时间:day 1
|
day 1
|
Comparison of the histological and inflammatory profiles of the EAT and the subcutaneous adipose tissue of each patients.
大体时间:day 1
|
day 1
|
Evaluation of the relations between the adipocytokines and cytokines profile in the EAT and coronary artery lesions.
大体时间:day 1
|
day 1
|
合作者和调查者
调查人员
- 首席研究员:Pascal LEPRINCE、Hôpital La Pitié Salpétrière Paris
研究记录日期
研究主要日期
学习开始
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (估计)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.
爱滋病毒感染的临床试验
-
Hospital Clinic of Barcelona完全的
-
Centers for Disease Control and PreventionGilead Sciences; CDC Foundation完全的
-
Rajavithi Hospital未知研究在放疗前和放疗最后一周接受放疗的 HIV 癌症患者的免疫状态 | 研究在放疗前和放疗最后一周接受放疗的 HIV 癌症患者的 HIV 病毒载量泰国
-
National Institute of Allergy and Infectious Diseases...完全的HIV-1 感染 | HIV抗体 | 中和抗体 | 病毒载量 | 单克隆抗体美国
-
AIDS Healthcare FoundationUniversity of California, Los Angeles完全的
-
ANRS, Emerging Infectious DiseasesInstitut National de la Santé Et de la Recherche Médicale, France; University of Bergen; Centre... 和其他合作者完全的
-
Hospital Universitari Vall d'Hebron Research InstituteGilead Sciences完全的
-
Hospital Universitari Vall d'Hebron Research InstituteUniversity Hospital, Ghent; IrsiCaixa完全的